SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Syschem India informs about update on petition

26 Feb 2024 Evaluate
Pursuant to regulation 30 of SEBI Listing Obligations and Disclosure Requirement) Regulation 2015, Syschem India has informed that the Company received a petition on 26th of February, 2024 from its Financial Creditor namely Lotus Builders filled before hon'ble NCLT Chandigarh Bench against the company with Dairy No 0404116006102024. The details of petition are enclosed. 

The above information is a part of company’s filings submitted to BSE.

Syschem (India) Share Price

50.91 1.53 (3.10%)
13-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×